# The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

> **NCT00002331** · NA · COMPLETED · sponsor: **Abbott**

## Conditions studied

- Mycobacterium Avium-intracellular Infection
- HIV Infections

## Interventions

- **DRUG:** Ethambutol hydrochloride
- **DRUG:** Clarithromycin
- **DRUG:** Clofazimine

## Key facts

- **NCT ID:** NCT00002331
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-01
- **Primary completion:** 1995-03
- **Final completion:** 1995-03
- **Target enrollment:** — (—)
- **Last updated:** 2015-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002331, "The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*